|
1
|
Loginova M, Mishchenko T, Savyuk M, Guseva
S, Gavrish M, Krivonosov M, Ivanchenko M, Fedotova J and Vedunova
M: Double-edged sword of vitamin D3 effects on primary neuronal
cultures in hypoxic states. Int J Mol Sci. 22(5417)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
AlJohri R, AlOkail M and Haq SH:
Neuroprotective role of vitamin D in primary neuronal cortical
culture. eNeurologicalSci. 14:43–48. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lardner AL: Vitamin D and hippocampal
development-the story so far. Front Mol Neurosci.
8(58)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Faye PA, Poumeaud F, Miressi F, Lia AS,
Demiot C, Magy L, Favreau F and Sturtz FG: Focus on
1,25-dihydroxyvitamin D3 in the peripheral nervous system. Front
Neurosci. 13(348)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
DeLuca GC, Kimball SM, Kolasinski J,
Ramagopalan SV and Ebers GC: Review: The role of vitamin D in
nervous system health and disease. Neuropathol Appl Neurobiol.
39:458–484. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gezen-Ak D, Yılmazer S and Dursun E: Why
vitamin D in Alzheimer's disease? The hypothesis. J Alzheimers Dis.
40:257–269. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lu'o'ng KV and Nguyễn LT: The beneficial
role of vitamin D in Alzheimer's disease. Am J Alzheimers Dis Other
Demen. 26:511–520. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Banerjee A, Khemka VK, Ganguly A, Roy D,
Ganguly U and Chakrabarti S: Vitamin D and Alzheimer's disease:
Neurocognition to therapeutics. Int J Alzheimers Dis.
2015(192747)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pignolo A, Mastrilli S, Davì C, Arnao V,
Aridon P, Dos Santos Mendes FA, Gagliardo C and D'Amelio M: Vitamin
D and Parkinson's disease. Nutrients. 14(1220)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Luo X, Ou R, Dutta R, Tian Y, Xiong H and
Shang H: Association between serum Vitamin D levels and Parkinson's
disease: A systematic review and meta-analysis. Front Neurol.
9(909)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Munger KL, Levin LI, Hollis BW, Howard NS
and Ascherio A: Serum 25-hydroxyvitamin D levels and risk of
multiple sclerosis. JAMA. 296:2832–2838. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Grau-López L, Granada ML, Raïch-Regué D,
Naranjo-Gómez M, Borràs-Serres FE, Martínez-Cáceres E and
Ramo-Tello C: Regulatory role of vitamin D in T-cell reactivity
against myelin peptides in relapsing-remitting multiple sclerosis
patients. BMC Neurol. 12(103)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mansoor F, Kumar V, Kumar S, Kaur N, Naz
S, Shahid S, Anees F, Memon S and Rizwan A: Association between
serum vitamin D levels and frequency of relapses in patients with
multiple sclerosis. Cureus. 13(e14383)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Landel V, Millet P, Baranger K, Loriod B
and Féron F: Vitamin D interacts with Esr1 and Igf1 to regulate
molecular pathways relevant to Alzheimer's disease. Mol
Neurodegener. 11(22)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gezen-Ak D, Atasoy IL, Candaş E,
Alaylioglu M, Yılmazer S and Dursun E: Vitamin D receptor regulates
amyloid beta 1-42 production with protein disulfide isomerase A3.
ACS Chem Neurosci. 8:2335–2346. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pike JW and Meyer MB: The vitamin D
receptor: New paradigms for the regulation of gene expression by
1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am. 38:13–27.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sutherland MK, Somerville MJ, Yoong LK,
Bergeron C, Haussler MR and McLachlan DR: Reduction of vitamin D
hormone receptor mRNA levels in Alzheimer as compared to huntington
hippocampus: Correlation with calbindin-28k mRNA levels. Brain Res
Mol Brain Res. 13:239–250. 1992.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Littlejohns TJ, Henley WE, Lang IA,
Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller
LH, Langa KM, et al: Vitamin D and the risk of dementia and
Alzheimer disease. Neurology. 83:920–928. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Alamro AA, Alsulami EA, Almutlaq M,
Alghamedi A, Alokail M and Haq SH: Therapeutic potential of vitamin
D and curcumin in an in vitro model of Alzheimer disease. J Cent
Nerv Syst Dis. 12(1179573520924311)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chai B, Gao F, Wu R, Dong T, Gu C, Lin Q
and Zhang Yi: Vitamin D deficiency as a risk factor for dementia
and Alzheimer's disease: An updated meta-analysis. BMC Neurol.
19(284)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gezen-Ak D, Dursun E, Ertan T, Hanagasi H,
Gurvit H, Emre M, Eker E, Ozturk M, Engin F and Yilmazer S:
Association between Vitamin D receptor gene polymorphism and
Alzheimer's disease. Tohoku J Exp Med. 212:275–282. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lehmann DJ, Refsum H, Warden DR, Medway C,
Wilcock GK and Smith AD: The vitamin D receptor gene is associated
with Alzheimer's disease. Neurosci Lett. 504:79–82. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Khorram Khorshid HR, Gozalpour E,
Saliminejad K, Karimloo M, Ohadi M and Kamali K: Vitamin D receptor
(VDR) polymorphisms and late-onset Alzheimer's disease: An
association study. Iran J Publ Health. 42:1253–1258.
2013.PubMed/NCBI
|
|
24
|
Łaczmański L, Jakubik M, Bednarek
Tupikowska G, Rymaszewska J, Słoka N and Lwow F: Vitamin D receptor
gene polymorphisms in Alzheimer's disease patients. Exp Gerontol.
69:142–147. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mun MJ, Kim MS, Kim JH and Jang WC: A TaqI
polymorphism of vitamin D receptor is associated with Alzheimer's
disease in Korean population: A case-control study. Int J Clin Exp
Med. 9:19268–19279. 2016.
|
|
26
|
Uitterlinden AG, Fang Y, Van-Meurs JB,
Pols HA and Van-Leeuwen J: Genetics and biology of vitamin D
receptor polymorphisms. Gene. 338:143–156. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gezen-Ak D, Dursun E, Bilgic B, Hanagasi
H, Ertan T, Gurvit H, Emre M, Eker E, Ulutin T, Uysal O and
Yilmazer S: Vitamin D receptor gene haplotype is associated with
late onset Alzheimer's disease. Tohoku J Exp Med. 228:189–196.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gezen-Ak D, Dursun E and Yilmazer S: The
effects of vitamin D receptor silencing on the expression of
LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons.
PLoS One. 6(e17553)2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gezen-Ak D, Dursun E and Yilmazer S: The
effect of vitamin D treament on nerve growth factor (NGF) release
from hippocampal neurons. Noro Psikiyatr Ars. 51:157–162.
2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dimitrakis E, Katsarou MS, Lagiou M,
Papastefanopoulou V, Stanitsa E, Spandidos DA, Tsatsakis A,
Papageorgiou S, Moutsatsou P, Antoniou K, et al: Association of
vitamin D receptor gene TaqI polymorphism with Alzheimer's disease
in a Southeastern European Caucasian population. Exp Ther Med.
23(341)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ruiz-Ballesteros AI, Meza-Meza MR,
Vizmanos-Lamotte B, Parra-Rojas I and de la Cruz-Mosso U:
Association of vitamin D metabolism gene polymorphisms with
autoimmunity: Evidence in population genetic studies. Int J Mol
Sci. 21(9626)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kuningas M, Mooijaart SP, Jolles J,
Slagboom PE, Westendorp RG and Van Heemst D: VDR gene variants
associate with cognitive function and depressive symptoms in old
age. Neurobiol Aging. 30:466–473. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Beydoun MA, Ding EL, Beydoun HA, Tanaka T,
Ferrucci L and Zonderman AB: Vitamin D receptor and megalin gene
polymorphisms and their associations with longitudinal cognitive
change in US adults. Am J Clin Nutr. 95:163–178. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Solé X, Guinó E, Valls J, Iniesta R and
Moreno V: SNPStats: A web tool for the analysis of association
studies. Bioinformatics. 22:1928–1929. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Dursun E, Gezen-Ak D and Yilmazer S: The
influence of vitamin D treatment on the inducible nitric oxide
synthase (INOS) expression in primary hippocampal neurons. Noro
Psikiyatr Ars. 51:163–168. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lauer AA, Griebsch LV, Pilz SM, Janitschke
D, Theiss EL, Reichrath J, Herr C, Beisswenger C, Bals R, Valencak
TG, et al: Impact of vitamin D3 deficiency on
phosphatidylcholine-/ethanolamine, plasmalogen,
lyso-phosphatidylcholine-/ethanolamine, carnitine- and triacyl
glyceride-homeostasis in neuroblastoma cells and murine brain.
Biomolecules. 11(1699)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Grimm MOW, Thiel A, Lauer AA, Winkler J,
Lehmann J, Regner L, Nelke C, Janitschke D, Benoist C,
Streidenberger O, et al: Vitamin d and its analogues decrease
amyloid-beta (abeta) formation and increase abeta-degradation. Int
J Mol Sci. 18(2764)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Oliveira ACR, Magalhães CA, Loures CMG,
Fraga VG, de Souza LC, Guimarães HC, Cintra MTG, Bicalho MA, Sousa
MCR, Silveira JN, et al: BsmI polymorphism in the vitamin D
receptor gene is associated with 25-hydroxy vitamin D levels in
individuals with cognitive decline. Arq Neuropsiquiatr. 76:760–766.
2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Niu H, Alvarez-Alvarez I, Guillen-Grima F
and Aguinaga-Ontoso I: Prevalence and incidence of Alzheimer's
disease in Europe: A meta-analysis. Neurologia. 32:523–532.
2017.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
40
|
Cui L, Hou NN, Wu HM, Zuo X, Lian YZ,
Zhang CN, Wang ZF, Zhang X and Zhu JH: Prevalence of Alzheimer's
disease and parkinson's disease in China: An updated systematical
analysis. Front Aging Neurosci. 12(603854)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rajan KB, Weuve J, Barnes LL, McAninch EA,
Wilson RS and Evans DA: Population estimate of people with clinical
Alzheimer's disease and mild cognitive impairment in the United
States (2020-2060). Alzheimers Dement. 17:1966–1975.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Beam CR, Kaneshiro C, Jang JY, Reynolds
CA, Pedersen NL and Gatz M: Differences between women and men in
incidence rates of dementia and Alzheimer's disease. J Alzheimer's
Dis. 64:1077–1083. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mielke MM: Sex and gender differences in
Alzheimer's disease dementia. Psychiatr Times. 35:14–17.
2018.PubMed/NCBI
|
|
44
|
Nebel RA, Aggarwal N, Barnes LL, Gallagher
A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L,
Yu WH, et al: Understanding the impact of sex and gender in
Alzheimer's disease: A call to action. Alzheimers Dement.
14:1171–1183. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xu H, Wang R, Zhang YW and Zhang X:
Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's
disease. Ann N Y Acad Sci. 1089:324–342. 2006.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liang K, Yang L, Yin C, Xiao Z, Zhang J,
Liu Y and Huang J: Estrogen stimulates degradation of beta-amyloid
peptide by up-regulating neprilysin. J Biol Chem. 285:935–942.
2010.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Marin R, Guerra B, Hernández-Jiménez JG,
Kang XL, Fraser JD, López FJ and Alonso R: Estradiol prevents
amyloid-beta peptide-induced cell death in a cholinergic cell line
via modulation of a classical estrogen receptor. Neuroscience.
121:917–926. 2003.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yagyu K, Kitagawa K, Wu B, Zhang NY, Irie
T, Hattori N and Inagaki C: Protective effects of estradiol against
amyloid beta protein-induced inhibition of neuronal Cl(-)-ATPase
activity. Neuropharmacology. 43:1297–1304. 2002.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Quintanilla RA, Muñoz FJ, Metcalfe MJ,
Hitschfeld M, Olivares G, Godoy JA and Inestrosa NC: Trolox and 17
beta-estradiol protect against amyloid beta-peptide neurotoxicity
by a mechanism that involves modulation of the Wnt signaling
pathway. J Biol Chem. 280:11615–11625. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Amtul Z, Wang L, Westaway D and Rozmahel
RF: Neuroprotective mechanism conferred by 17beta-estradiol on the
biochemical basis of Alzheimer's disease. Neuroscience.
169:781–786. 2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Levin-Allerhand JA, Lominska CE, Wang J
and Smith JD: 17Alpha-estradiol and 17beta-estradiol treatments are
effective in lowering cerebral amyloid-beta levels in AbetaPPSWE
transgenic mice. J Alzheimers Dis. 4:449–457. 2002.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kinuta K, Tanaka H, Moriwake T, Aya K,
Kato S and Seino Y: Vitamin D is an important factor in estrogen
biosynthesis of both female and male gonads. Endocrinology.
141:1317–1324. 2000.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Enjuanes A, Garcia-Giralt N, Supervia A,
Nogues X, Mellibovsky L, Carbonell J, Grinberg D, Balcells S and
Díez-Pérez A: Regulation of CYP19 gene expression in primary human
osteoblasts: Effects of vitamin D and other treatments. Eur J
Endocrinol. 148:519–526. 2003.PubMed/NCBI View Article : Google Scholar
|
